Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001062993-24-009327 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-03 | 2024-05-01 | ACH | Bernocchi Perry A | EVP, CEO, Patient Direct | S - Sale | $24.31 | -24.1K | 170.5K | -12% | -$585.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-01 | S | D | 3,890 | $24.53 | 190,701 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. |
| 2 | Common | Common Stock | 2024-05-01 | S | D | 20,204 | $24.27 | 170,497 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. (F2) Weighted average of the sale price range of $23.870 - $24.800 |